Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to $1.8 million.

  • BrightSpring Health Services' Gains from Investment Securities rose 19500.0% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year decrease of 4080.47%. This contributed to the annual value of $25.0 million for FY2024, which is 3345.69% down from last year.
  • Per BrightSpring Health Services' latest filing, its Gains from Investment Securities stood at $1.8 million for Q3 2025, which was up 19500.0% from $9.6 million recorded in Q2 2025.
  • Over the past 5 years, BrightSpring Health Services' Gains from Investment Securities peaked at $22.8 million during Q2 2023, and registered a low of $620000.0 during Q3 2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was $3.7 million (2023), whereas its average is $7.0 million.
  • The largest annual percentage gain for BrightSpring Health Services' Gains from Investment Securities in the last 5 years was 19989.28% (2024), contrasted with its biggest fall of 9317.48% (2024).
  • Quarter analysis of 3 years shows BrightSpring Health Services' Gains from Investment Securities stood at $1.9 million in 2023, then plummeted by 65.52% to $641000.0 in 2024, then soared by 185.34% to $1.8 million in 2025.
  • Its Gains from Investment Securities was $1.8 million in Q3 2025, compared to $9.6 million in Q2 2025 and $3.4 million in Q1 2025.